MMSI Merit Medical Systems
- 80.910
- +0.480+0.60%
Merit Medical Systems News
Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching
Merit Medical Systems, Inc. (NASDAQ:MMSI), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQGS. The recent share p
Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
On CNBC's "Mad Money Lightning Round," Jim Cramer said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a "terrific spec" and he recommended buying the same.On May 9, Recursion Pharmaceuticals reporte
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
South Jordan, UT-headquartered Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology.
Merit Medical Launches BasixSKY Inflation Device
SOUTH JORDAN, Utah, May 21, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced the US commercial release of the basixSKY Inflation Device.
Merit Medical Systems Announces New President and Executive Compensation
Press Release: Merit Medical Shareholders Elect Silvia M. Perez as New Director
Merit Medical Shareholders Elect Silvia M. Perez as New Director Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership
Merit Medical Board Continues to Seek CEO Candidates in Preparation for Retirement of Fred Lampropoulos at End of 2025 >MMSI
Merit Medical Board Continues to Seek CEO Candidates in Preparation for Retirement of Fred Lampropoulos at End of 2025 >MMSI
Merit Medical Appoints Chief Commercial Officer Joe Wright as President >MMSI
Merit Medical Appoints Chief Commercial Officer Joe Wright as President >MMSI
Merit Medical (MMSI) to Expand Product Suite Via New Launch
Merit Medical Expands Embolics Portfolio With New Siege Vascular Plug and Bearing NsPVA Express Prefilled Syringe
New products broaden Merit's leadership in embolotherapy.Full portfolio will be exhibited at the 18th Annual GEST Meeting May 16-19 in New York City. SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit
We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems
Merit Medical Price Target Cut to $102.00/Share From $112.00 by Canaccord Genuity
Merit Medical Price Target Cut to $102.00/Share From $112.00 by Canaccord Genuity
Merit Medical Is Maintained at Buy by Canaccord Genuity
Merit Medical Is Maintained at Buy by Canaccord Genuity
The Analyst Landscape: 11 Takes On Merit Medical Systems
Merit Medical Systems (NASDAQ:MMSI) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a concise over
Barrington Research: Maintaining the Merit Medical Systems (MMSI.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $98.00 to $100.00.
Barrington Research: Maintaining the Merit Medical Systems (MMSI.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $98.00 to $100.00.
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2024 Earnings Call Transcript
Barrington Raises Adjusts Price Target on Merit Medical Systems to $100 From $98, Maintains Outperform Rating
Merit Medical Systems (MMSI) has an average rating of outperform and price targets ranging from $80 to $112, according to analysts polled by Capital IQ.
Bank of America Securities Keeps Their Hold Rating on Merit Medical Systems (MMSI)
Analysis
Price Target
No Data
